Neurological Disorders and Diseases

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA ALERT
Brain image
FDA ALERT
FDA Approves Avlayah (Tividenofusp Alfa-Eknm) for Neurologic Manifestations of Hunter Syndrome in Pediatric Patients
03/26/2026
Ashton L. Stahl
The FDA has approved Avlayah (tividenofusp alfa-eknm) for certain pediatric patients with Hunter syndrome, marking the first approval targeting the disease's neurologic complications and offering clinicians...
03/26/2026
FDA Alert
blood clot
FDA Alert
FDA Approves First Treatment for Adult, Pediatric Patients With Rare Inherited Blood Clotting Disorder
02/07/2024
Jessica Ganga
The FDA approved the first treatment for patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and life-threatening blood clotting disorder that may be fatal if left...
02/07/2024
FDA alert
test tubes
FDA alert
FDA Approves Biosimilar Treatment for Patients With Multiple Sclerosis
11/14/2023
Jessica Ganga
The FDA has approved the first biosimilar treatment for patients living with relapsing forms of multiple sclerosis.
11/14/2023
Treatment
Treatment
FDA Accelerates Approval for New Alzheimer Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
Neurological Disorders and Diseases
Neurological Disorders and Diseases
FDA Approves New Treatment for Form of Batten Disease
04/27/2017
The US Food and Drug Administration has approved a new option for the treatment of a specific form of Batten disease in pediatric patients aged 3 years and older.
04/27/2017
Movement Disorders
Movement Disorders
FDA Approves Austedo for Treatment of Huntington Disease-Associated Chorea
04/04/2017
The US Food and Drug Administration has approved Austedo (deutetrabenazine) tablets for the treatment of chorea in patients with Huntington disease.
04/04/2017